Drug Name Indication Neurotransmitter(s) Affected Target Symptoms Half-life (T1/2), Metabolism (CYP 450 enzyme) Notable Side Effects (link to NT

Drug Name

Indication

Neurotransmitter(s) Affected

Target Symptoms

Half-life (T1/2), Metabolism (CYP 450 enzyme)

Notable Side Effects (link to NT or affected brain circuit)

Initial Dosing Considerations

Specific lifespan considerations (age, pregnancy, breastfeeding)

Buprenorphine (Subutex)

Buprenorphine/Naloxone (Suboxone, Zubsolv, Bunavail)

Methadone (Dolophine, Methadose)

Naltrexone (Revia, Vivitrol)

Acamprosate (Campral)

Disulfiram (Antabuse)

Instructions below:

1. For each medication listed, complete the following:

a. Provide indication, target symptoms, and affected neurotransmitters.

b. Include half-life and CYP 450 enzyme information.

c. List notable side effects and link notable side effects to the associated pathway or neurotransmitter.

d. List Initial Dosing Considerations and specific lifespan considerations (age, pregnancy, breastfeeding).

e. Organization font is consistent throughout table, grammar, spelling, and/or punctuation are accurate.

f.

Share This Post

Email
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Reddit

Order a Similar Paper and get 15% Discount on your First Order

Related Questions

Neurotransmitter Table Neuro transmitter

Neurotransmitter Table Neuro transmitter Receptor Subtype Location/Function/Effects/symptoms of excess or deficit if applicable Distribution (ie: CNS/PNS, GI, vascular) Drug classes that target this neurotransmitter or receptor Specific medications that target this neurotransmitter or receptor Glutamate AMPA NMDA GABA GABA a GABA b Serotonin 5HT 5HT 1a 5HT 1B 5HT 1d

READ BELOW: 1. 1.  chose Atomoxetine for this patient.  2. List medication class and mechanism of action for the chosen medication. 1. According to Stahl

READ BELOW: 1. 1.  chose Atomoxetine for this patient.  2. List medication class and mechanism of action for the chosen medication. 1. According to Stahl (2021), this drug is a norepinephrine reuptake inhibitor and a selective norepinephrine inhibitor. Atomoxetine boosts norepinephrine/noradrenaline and increased dopamine in the prefrontal cortex. It also